Laryngeal and Hypopharyngeal Cancer Early Detection, Diagnosis, and Staging Detection and Diagnosis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Metformin Increases Survival in Hypopharyngeal Cancer Patients with Diabetes Mellitus: Retrospective Cohort Study and Cell-Based Analysis
pharmaceuticals Article Metformin Increases Survival in Hypopharyngeal Cancer Patients with Diabetes Mellitus: Retrospective Cohort Study and Cell-Based Analysis Yung-An Tsou 1,2, Wei-Chao Chang 3, Chia-Der Lin 1, Ro-Lin Chang 2, Ming-Hsui Tsai 1, Liang-Chun Shih 1,3, Theresa Staniczek 4 , Tsu-Fang Wu 1, Hui-Ying Hsu 3, Wen-Dien Chang 5 , Chih-Ho Lai 6,7,8,9,* and Chuan-Mu Chen 2,10,* 1 Department of Otolaryngology-Head and Neck Surgery, China Medical University Hospital, Taichung 406, Taiwan; [email protected] (Y.-A.T.); [email protected] (C.-D.L.); [email protected] (M.-H.T.); [email protected] (L.-C.S.); [email protected] (T.-F.W.) 2 Department of Life Sciences, Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung 402, Taiwan; [email protected] 3 Center for Molecular Medicine, Graduate Institute of Biomedical Sciences, China Medical University, Taichung 406, Taiwan; [email protected] (W.-C.C.); [email protected] (H.-Y.H.) 4 Department of Dermatology, Venereology and Allergology, University Medical Center and Medical Faculty Mannheim, Center of Excellence in Dermatology, Heidelberg University, 68167 Mannheim, Germany; [email protected] 5 Department of Sport Performance, National Taiwan University of Sport, Taichung 404, Taiwan; Citation: Tsou, Y.-A.; Chang, W.-C.; [email protected] 6 Department of Microbiology and Immunology, Graduate Institute of Biomedical Sciences, Lin, C.-D.; Chang, R.-L.; Tsai, M.-H.; College of Medicine, Chang Gung University, Taoyuan 333, Taiwan Shih, L.-C.; Staniczek, T.; Wu, T.-F.; 7 Department of Pediatrics, Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Hsu, H.-Y.; Chang, W.-D.; et al. -
Early Response to Chemotherapy in Hypopharyngeal Cancer: Assessment with 11C- Methionine PET, Correlation with Morphologic Response, and Clinical Outcome
Early Response to Chemotherapy in Hypopharyngeal Cancer: Assessment with 11C- Methionine PET, Correlation with Morphologic Response, and Clinical Outcome Eric Chesnay, MD1; Emmanuel Babin, MD2; Jean Marc Constans, MD3; Denis Agostini, MD, PhD1; Arnaud Bequignon, MD2; Armelle Regeasse, MSc4; Franck Sobrio, MSc5; and Sylvain Moreau, MD2–6 1Department of Nuclear Medicine, University Hospital, Caen, France; 2Department of Head and Neck Surgery, University Hospital, Caen, France; 3Department of Radiology, University Hospital, Caen, France; 4Department of Medical Informatics and Epidemiology, University Hospital, Caen, France; 5Cyceron PET Center, Commissariat a` l’Energie Atomique/Direction des Sciences du Vivant, Caen, France; and 6Laboratory of Anatomy, University Hospital, Caen, France physicians in treatment planning by avoiding unnecessary che- Neoadjuvant chemotherapy in hypopharyngeal cancer globally motherapy courses for nonresponding patients. improves survival, but some patients do not respond to chemo- Key Words: PET; 11C-methionine; chemotherapy monitoring; therapy and adjuvant therapy is delayed. Prediction of response hypopharyngeal cancer to chemotherapy may allow physicians to optimize planned J Nucl Med 2003; 44:526–532 treatment. The aim of this study was to compare treatment response assessed early with 11C-methionine PET and morpho- logic response assessed after treatment completion with MRI. Methods: Thirteen patients with previously untreated squa- mous cell carcinoma of the hypopharynx, T3 or T4, were in- Chemotherapy and radiotherapy have made avoiding or cluded. All patients received 3 courses of chemotherapy com- delaying surgery in hypopharyngeal cancer possible. How- prising cisplatin and 5-fluorouracil. 11C-Methionine PET was ever, if improvement in the quality of life has been demon- performed before and after the first course of chemotherapy. -
Emerging Concepts and Novel Strategies in Radiation Therapy for Laryngeal Cancer Management
cancers Review Emerging Concepts and Novel Strategies in Radiation Therapy for Laryngeal Cancer Management Mauricio E. Gamez 1,*, Adriana Blakaj 2, Wesley Zoller 1 , Marcelo Bonomi 3 and Dukagjin M. Blakaj 1 1 Division of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA; [email protected] (W.Z.); [email protected] (D.M.B.) 2 Department of Therapeutic Radiology, Yale School of Medicine, 35 Park St., New Haven, CT 06519, USA; [email protected] 3 Department of Internal Medicine, Division of Medical Oncology, The Ohio State University Wexner Medical Center, 320 West 10th Avenue, Columbus, OH 43210, USA; [email protected] * Correspondence: [email protected] Received: 25 May 2020; Accepted: 15 June 2020; Published: 22 June 2020 Abstract: Laryngeal squamous cell carcinoma is the second most common head and neck cancer. Its pathogenesis is strongly associated with smoking. The management of this disease is challenging and mandates multidisciplinary care. Currently, accepted treatment modalities include surgery, radiation therapy, and chemotherapy—all focused on improving survival while preserving organ function. Despite changes in smoking patterns resulting in a declining incidence of laryngeal cancer, the overall outcomes for this disease have not improved in the recent past, likely due to changes in treatment patterns and treatment-related toxicities. Here, we review emerging concepts and novel strategies in the use of radiation therapy in the management of laryngeal squamous cell carcinoma that could improve the relationship between tumor control and normal tissue damage (therapeutic ratio). Keywords: laryngeal cancer; radiotherapy; IMRT; IGRT; SABR; de-escalation therapy 1. -
Epiglottis Reconstruction with Auricular Free Flap For
ISSN: 2572-4193 Bottini et al. J Otolaryngol Rhinol 2017, 3:032 DOI: 10.23937/2572-4193.1510032 Volume 3 | Issue 2 Journal of Open Access Otolaryngology and Rhinology CASE REPORT Epiglottis Reconstruction with Auricular Free Flap for Re- habilitation of Dysphagia: A Case Study Battista Bottini G1*, Brandtner C1, Rasp G2 and Gaggl A1 1Department of Oral and Maxillofacial Surgery, University Hospital, Private Medical University Paracelsus, Austria 2Department of Ear, Nose and Throat, University Hospital, Private Medical University Paracelsus, Check for updates Austria *Corresponding author: Gian Battista Bottini, MD, DMD, Department of Oral and Maxillofacial Surgery, Uni- versity Hospital, Private Medical University Paracelsus, 48 Muellner Hauptstrasse, 5020 Salzburg, Austria, Tel: +43(0)57255-57230, Fax: +43(0)57255-26499, E-mail: [email protected] and requires a coordinated activity of nerves, muscles, Abstract the hyoid bone and the larynx [1]. The process can be Supraglottic laryngectomy for laryngeal cancer aims to remove divided in stages: oral pharyngeal and oesophageal [1]. cancer of the larynx whilst preserving its functions of airway protection, breathing and voice production. A well-known long- During the pharyngeal stage, the vocal cords adduct term complication of this procedure is aspiration. to seal the glottis and the arytenoid tilt forward to con- We present a case of a delayed epiglottis reconstruction tact the epiglottis base. with auricular free flap for surgical rehabilitation of dyspha- gia. Primarily the patient underwent supraglottic laryngecto- When the hyo-laryngeal complex is pulled in anterior my, bilateral neck dissection and radiotherapy. She had a and superior direction against the base of the tongue, permanent tracheostoma because of a complete paralysis the epiglottis, acting like a shield, tilts backwards and of the right vocal cord and a residual minimal mobility of the covers completely the glottis [1]. -
Medical Term for Throat
Medical Term For Throat Quintin splined aerially. Tobias griddles unfashionably. Unfuelled and ordinate Thorvald undervalues her spurges disroots or sneck acrobatically. Contact Us WebsiteEmail Terms any Use Medical Advice Disclaimer Privacy. The medical term for this disguise is called formication and it been quite common. How Much sun an Uvulectomy in office Cost on Me MDsave. The medical term for eardrum is tympanic membrane The direct ear is. Your throat includes your esophagus windpipe trachea voice box larynx tonsils and epiglottis. Burning mouth syndrome is the medical term for a sequence-lastingand sometimes very severeburning sensation in throat tongue lips gums palate or source over the. Globus sensation can sometimes called globus pharyngeus pharyngeus refers to the sock in medical terms It used to be called globus. Other medical afflictions associated with the pharynx include tonsillitis cancer. Neil Van Leeuwen Layton ENT Doctor Tanner Clinic. When we offer a throat medical conditions that this inflammation and cutlery, alcohol consumption for air that? Medical Terminology Anatomy and Physiology. Empiric treatment of the lining of the larynx and ask and throat cancer that can cause nasal cavity cancer risk of the term throat muscles. MEDICAL TERMINOLOGY. Throat then Head wrap neck cancers Cancer Research UK. Long term monitoring this exercise include regular examinations and. Long-term a frequent exposure to smoke damage cause persistent pharyngitis. Pharynx Greek throat cone-shaped passageway leading from another oral and. WHAT people EXPECT ON anything LONG-TERM BASIS AFTER A LARYNGECTOMY. Sensation and in one of causes to write the term for throat medical knowledge. The throat pharynx and larynx is white ring-like muscular tube that acts as the passageway for special food and prohibit It is located behind my nose close mouth and connects the form oral tongue and silk to the breathing passages trachea windpipe and lungs and the esophagus eating tube. -
Laryngeal Cancer Survivorship
About the Authors Dr. Yadro Ducic MD completed medical school and Head and Neck Surgery training in Ottawa and Toronto, Canada and finished Facial Plastic and Reconstructive Surgery at the University of Minnesota. He moved to Texas in 1997 running the Department of Otolaryngology and Facial Plastic Surgery at JPS Health Network in Fort Worth, and training residents through the University of Texas Southwestern Medical Center in Dallas, Texas. He was a full Clinical Professor in the Department of Otolaryngology-Head Neck Surgery. Currently, he runs a tertiary referral practice in Dallas-Fort Worth. He is Director of the Baylor Neuroscience Skullbase Program in Fort Worth, Texas and the Director of the Center for Aesthetic Surgery. He is also the Codirector of the Methodist Face Transplant Program and the Director of the Facial Plastic and Reconstructive Surgery Fellowship in Dallas-Fort Worth sponsored by the American Academy of Facial Plastic and Reconstructive Surgery. He has authored over 160 publications, being on the forefront of clinical research in advanced head and neck cancer and skull base surgery and reconstruction. He is devoted to advancing the care of this patient population. For more information please go to www.drducic.com. Dr. Moustafa Mourad completed his surgical training in Head and Neck Surgery in New York City from the New York Eye and Ear Infirmary of Mt. Sinai. Upon completion of his training he sought out specialization in facial plastic, skull base, and reconstructive surgery at Baylor All Saints, under the mentorship and guidance of Dr. Yadranko Ducic. Currently he is based in New York City as the Division Chief of Head and Neck and Skull Base Surgery at Harlem Hospital, in addition to being the Director for the Center of Aesthetic Surgery in New York. -
Hypopharyngeal Cancer
Hypopharyngeal cancer The name ‘Beyond Five’ refers to the long-term support that patients with head and neck cancer often need, which often extends beyond five years after diagnosis. CONTENTS What is the hypopharynx? .................................................................................................................................. 2 What does the hypopharynx do? ........................................................................................................................ 3 What is hypopharyngeal cancer? ........................................................................................................................ 3 What causes hypopharyngeal cancer? ................................................................................................................ 3 What are the signs and symptoms of hypopharyngeal cancer? ......................................................................... 4 How is hypopharyngeal cancer diagnosed? ........................................................................................................ 5 The cancer care team .......................................................................................................................................... 7 What is staging and grading? .............................................................................................................................. 8 Treatment options for hypopharyngeal cancer ................................................................................................ 10 Surgery -
Vocalist (Singer/Actor)
Vocalist (Singer/Actor) Practitioner 1. Timbre--the perceived sound quality of a musical note or tone that distinguishes different types of sounds from one another 2. Head Voice--a part of the vocal range in which sung notes cause the singer to perceive a vibratory sensation in his or her head 3. Chest Voice-- a part of the vocal range in which sung notes cause the singer to perceive a vibratory sensation in his or her chest 4. Middle Voice-- a part of the vocal range which exists between the head voice and chest voice in a female vocalist 5. Falseto Voice--a part of the vocal range the exist above the head voice in a male vocalist 6. Tessitura—the most musically acceptable and comfortable vocal range for a given singer 7. Modal Voice--the vocal register used most frequently in speech and singing; also known as the resonant mode of the vocal cords, it is the optimal combination of airflow and glottal tension that yields maximum vibration 8. Passaggio--the term used in classical singing to describe the transition between vocal registers (i.e. head voice, chest voice, etc.) 9. Belting—a specific technique of singing by which a singer brings his or her chest register above its natural break point at a loud volume; often described and felt as supported and sustained yelling 10. Melisma—a passage of multiple notes sung to one syllable of text 11. Riffs and Runs –melodic notes added by the singer to enhance the expression and emotional intensity of a song; a form of vocal embellishments during singing 12. -
NCCN Guidelines for Head and Neck Cancers V.1.2019 – Follow-Up on 01/17/2019
NCCN Guidelines for Head and Neck Cancers V.1.2019 – Follow-Up on 01/17/2019 Guideline Page Panel Discussion/References Institution Vote and Request YES NO ABSTAIN ABSENT SALI-4/CHEM-A Based on a review of data and discussion, the panel 21 0 2 4 External request: consensus supported the inclusion of NTRK therapy (eg, larotrectinib) as an option for recurrent NTRK gene fusion- Submission from Bayer HealthCare positive salivary gland tumors with distant metastases, PS Pharmaceuticals suggesting the following for 0-3 (on page SALI-4). This is a category 2A consideration: recommendation. 1. Principles of Systemic Therapy: Add bullet “Larotrectinib is recommended for tumors harboring an NTRK gene fusion.” See Submission for references. 2. First-line Single-agent or Second- line/Subsequent Therapy: Add “larotrectinib if NTRK+” 3. Salivary Gland Tumors, Unresectable Disease or Distant Metastases: Add “larotrectinib if NTRK+” CHEM-A (1 of 6) Based on the discussion and noted references, the panel Internal request: consensus was that cetuximab + concurrent RT has limited clinical use for the primary treatment of: Panel comment to review the data for cetuximab Hypopharynx, larynx, p16-negative oropharynx 16 5 2 4 + concurrent RT as a primary definitive therapy cancers option for oropharyngeal cancer (p16-negative p16-positive oropharynx cancers 10 10 3 4 and p16-positive), hypopharyngeal cancer, and The category was changed from a category 1 to a 2B laryngeal cancer. recommendation for cancers of the oropharynx (p16- positive and p16-negative), hypopharynx or larynx. References: Gillison ML, Trotti AM, Harris J, et al. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. -
What You Need to Know About™ Cancer of the Larynx
What You Need To Know About TM Cancer National Cancer Institute of the Larynx U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute Services This is only one of many free booklets for people with cancer. You may want more information for yourself, your family, and your doctor. NCI offers comprehensive research-based information for patients and their families, health professionals, cancer researchers, advocates, and the public. • Call NCI’s Cancer Information Service at 1–800–4–CANCER (1–800–422–6237) • Visit us at http://www.cancer.gov or http://www.cancer.gov/espanol • Chat using LiveHelp, NCI’s instant messaging service, at http://www.cancer.gov/ livehelp • E-mail us at [email protected] • Order publications at http://www.cancer.gov/ publications or by calling 1–800–4–CANCER • Get help with quitting smoking at 1–877–44U–QUIT (1–877–448–7848) Contents About This Booklet 1 The Larynx 2 Cancer Cells 5 Risk Factors 7 Symptoms 9 Diagnosis 9 Staging 12 Treatment 13 Second Opinion 25 Nutrition 26 Rehabilitation 27 Follow-up Care 29 Sources of Support 29 Taking Part in Cancer Research 31 Dictionary 32 National Cancer Institute Publications 40 National Institute on Deafness and Other Communication Disorders 42 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health About This Booklet This National Cancer Institute (NCI) booklet is about cancer* that starts in the larynx. Another name for this disease is laryngeal cancer. Each year in the United States, more than 10,000 men and about 3,000 women learn they have cancer of the larynx. -
Comparative Anatomy of the Larynx and Related Structures
Research and Reviews Comparative Anatomy of the Larynx and Related Structures JMAJ 54(4): 241–247, 2011 Hideto SAIGUSA*1 Abstract Vocal impairment is a problem specific to humans that is not seen in other mammals. However, the internal structure of the human larynx does not have any morphological characteristics peculiar to humans, even com- pared to mammals or primates. The unique morphological features of the human larynx lie not in the internal structure of the larynx, but in the fact that the larynx, hyoid bone, and lower jawbone move apart together and are interlocked via the muscles, while pulled into a vertical position from the cranium. This positional relationship was formed because humans stand upright on two legs, breathe through the diaphragm (particularly indrawn breath) stably and with efficiency, and masticate efficiently using the lower jaw, formed by membranous ossification (a characteristic of mammals).This enables the lower jaw to exert a pull on the larynx through the hyoid bone and move freely up and down as well as regulate exhalations. The ultimate example of this is the singing voice. This can be readily understood from the human growth period as well. At the same time, unstable standing posture, breathing problems, and problems with mandibular movement can lead to vocal impairment. Key words Comparative anatomy, Larynx, Standing upright, Respiration, Lower jawbone Introduction vocal cord’s mucous membranes to wave tends to have a morphology that closely resembles that of Animals other than humans also use a wide humans, but the interior of the thyroarytenoid range of vocal communication methods, such as muscles—i.e., the vocal cord muscles—tend to be the frog’s croaking, the bird’s chirping, the wolf’s poorly developed in animals that do not vocalize howling, and the whale’s calls. -
Evaluation and Management of the Patient with a Neck Mass
Head & Neck Tumours Part II Content • Tumours of the Ears • Tumours of the Nose • Tumours of the Mouth • Tumours of the Pharynx • Tumours of the Larynx Neoplasms of the Ear and Lateral Skull Base • Lesions of the Pinna and EAC • Lesions of the Middle Ear and Mastoid • Lesions of the Petrous Apex and Clivus • Lesions of the IAC, CPA, and Skull Base Introduction • Generally classified by location, and occasionally by cell-type • Causes of these neoplasms are largely unknown? Neoplasms of the pinna and external auditory canal Cutaneous carcinoma Osteoma and exostosis Squamous cell carcinoma Basal cell carcinoma Miscellaneous neoplasm Merkel cell carcinoma Squamous papilloma Malignant melanoma Pilomatrixoma Myxoma Glandular neoplasm Auricular endochondrial Ceruminous adenoma pseudocyst Ceruminous adenocarcinoma Chondrodermatitis nodularis Pleomorphic adenoma chronica helicis (Winkler disease) Adenoid cystic carcinoma Lesions of the Petrous Apex and Clivus • Adenomatous neoplasm • Langerhans cell histiocytosis Benign middle ear adenoma Eosinophilic granuloma Endolymphatic sac tumor Hand-Schüller-Christian disease Letterer-Siwe disease Chordoma Sarcoma Rhabdomyosarcoma Chondrosarcoma Congenital neoplasm Ewing sarcoma Dermoid Osteogenic sarcoma Teratoma Fibrosarcoma Choristoma Cholesterol granuloma Neoplasms of the internal auditory canal and cerebellopontine angle Schwannoma Vestibular schwannoma Facial nerve schwannoma Trigeminal schwannoma Jugular foramen schwannoma Meningioma Lipoma Metastases Neoplasms of the Pinna and EAC Cutaneous Carcinoma BCC • BCC (20% of ear/TB neoplasms) • Most on pinna • Sun exposure is initiator • Locally infiltrative, rolled border central crusting ulcer • May invade TB if left untreated Cutaneous Carcinoma SCCA • Pinna and EAC are common • Sun, cold, radiation are all factors • Scaly irregular indurated maculopapular lesion, often ulcerated with sero-sang d/c • Can be confused with OE • Other symptoms VII, CHL, SNHL (with invasion of TB) • Met.